Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...
Clinically proven to visibly reduce discoloration and help prevent future pigment formation, the new serum marks a major advancement in biotech skincare innovation. Powered by patented MI9™ peptide, ...
Will leverage PolyPeptide’s peptide manufacturing and development services and Lifecore’s formulation, fill/finish, and packaging services.
Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and PolyPeptide Laboratories, Inc. (“PolyPeptide”), a global ...
Sai Life Sciences Limited has announced a new CMC Process R&D Center at its Hyderabad campus, set to double its Process R&D ...
Arch Biopartners (($TSE:ARCH)) announced an update on their ongoing clinical study. Arch Biopartners is conducting a Phase 2 global study titled ...
TipRanks on MSN
Pangea’s Amino Innovations Partners with University of Alberta for Peptide Advancements
The latest update is out from Pangea Natural Food, Inc. ( (TSE:PNGA) ).
6d
Cura Unveils First-of-Its-Kind Peptide Hair Growth Serum Manufactured at Scale in the United States
The Peptide Hair Growth Serum is available through Cura’s official website.
Pangea Natural Foods Inc. (CSE:PNGA) (OTC: PNGAF) (" Pangea " or the " Company"), is excited to announce that its wholly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback